Argent Biopharma Ltd
RGT
Company Profile
Business description
Argent Biopharma Ltd is an innovative drug discovery company that addresses unmet medical needs by combining PolyPharmacology and Nanotechnology, aspiring to be a renowned global leader in the biopharmaceutical sector. Its products includes CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury and ARDS and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development.
Contact
295 Rokeby Road
Suite 1
Subiaco WA 6008
AUST: +61 865552950
E: info@mgcpharma.com.au
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2024
Employees
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 7,994.20 | 82.50 | -1.02% |
CAC 40 | 8,126.39 | 5.02 | -0.06% |
DAX 40 | 18,546.07 | 47.69 | 0.26% |
Dow JONES (US) | 39,056.39 | 172.13 | 0.44% |
FTSE 100 | 8,352.89 | 1.16 | -0.01% |
HKSE | 18,519.63 | 205.77 | 1.12% |
NASDAQ | 16,302.76 | 29.80 | -0.18% |
Nikkei 225 | 38,073.98 | 128.39 | -0.34% |
NZX 50 Index | 11,746.58 | 36.31 | -0.31% |
S&P 500 | 5,187.67 | 0.03 | -0.00% |
S&P/ASX 200 | 7,721.60 | 82.90 | -1.06% |
SSE Composite Index | 3,154.32 | 25.84 | 0.83% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Sayona Mining Ltd SYA | 0.04 | 0.00 | 8.11% |
Sigma Healthcare Ltd SIG | 1.29 | 0.01 | -0.77% |
Imugene Ltd IMU | 0.07 | 0.01 | -6.67% |
Vicinity Centres VCX | 1.92 | 0.02 | -1.03% |
Pilbara Minerals Ltd PLS | 4.17 | 0.01 | -0.24% |
Strike Energy Ltd STX | 0.24 | 0.02 | 6.82% |
Liontown Resources Ltd LTR | 1.40 | 0.07 | 5.26% |
Westpac Banking Corp WBC | 26.32 | 1.57 | -5.63% |
Telstra Group Ltd TLS | 3.64 | 0.01 | -0.27% |
South32 Ltd S32 | 3.62 | 0.03 | -0.82% |